Connect with us

Health

PARAGON-HF: Sacubitril/valsartan reduces triglyceride levels in HFpEF – Healio

Sacubitril/valsartan drastically reduced triglycerides compared with valsartan in patients with HF with preserved ejection fraction, according to a presentation…

Published

on

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Sacubitril/valsartan drastically reduced triglycerides compared with valsartan in patients with HF with preserved ejection fraction, according to a presentation at the American College of Cardiology Scientific Session.
In the analysis from the PARAGON-HF study, simultaneously published in the Journal of the American Heart Association, the effect…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending